SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-507531
Filing Date
2016-03-17
Accepted
2016-03-17 07:57:33
Documents
14
Period of Report
2016-05-03
Effectiveness Date
2016-03-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d126231ddef14a.htm DEF 14A 751799
2 GRAPHIC g126231g08o69.jpg GRAPHIC 59278
3 GRAPHIC g126231g16g78.jpg GRAPHIC 50431
4 GRAPHIC g126231g44n86.jpg GRAPHIC 134438
5 GRAPHIC g126231g52a93.jpg GRAPHIC 177874
6 GRAPHIC g126231g69n77.jpg GRAPHIC 7047
7 GRAPHIC g126231g72u86.jpg GRAPHIC 97074
8 GRAPHIC g126231g74q49.jpg GRAPHIC 177494
9 GRAPHIC g126231pc01a.jpg GRAPHIC 36923
10 GRAPHIC g126231pc01b.jpg GRAPHIC 45399
11 GRAPHIC g126231pc01c.jpg GRAPHIC 8293
12 GRAPHIC g126231pc01d.jpg GRAPHIC 15374
13 GRAPHIC g126231pc02.jpg GRAPHIC 8242
14 GRAPHIC g126231pc_pg001f.jpg GRAPHIC 37188
  Complete submission text file 0001193125-16-507531.txt   1932596
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36407 | Film No.: 161511257
SIC: 2834 Pharmaceutical Preparations